CDNA - Caredx Inc
IEX Last Trade
30.69
-0.220 -0.717%
Share volume: 1,470,396
Last Updated: Fri 30 Aug 2024 09:59:59 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$30.91
-0.22
-0.71%
Summary score
8%
Profitability
0%
Dept financing
9%
Liquidity
69%
Performance
2%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2020 - 30-Jun-2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-6.01%
Return on assets
-2.95%
Return on sales
-20.43%
Return on invested capital
-28.51%
Total debt ratio
23.63%
Debt ratio change over timeo
-4.55%
Current Ratio
5.41%
Quick Ratio
5.17%
Cash Position Ratio
4.27%
Short-term ratios 30-Jun-2023 - 30-Jun-2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-14.54%
Return on assets
-4.05%
Return on sales
-27.99%
Return on invested capital
-52.17%
Total debt ratio
38.01%
Debt ratio change over timeo
-7.26%
Current Ratio
4.29%
Quick Ratio
4.04%
Cash Position Ratio
3.18%
Last quarter ratios 30-Jun-2024
The data are presented for the financials results of the last quarter.
Return on equity
-0.53%
Return on assets
-0.86%
Return on sales
-4.37%
Return on invested capital
-2.05%
Total debt ratio
43.3%
Debt ratio change over time
-22.07%
Current Ratio
4.09%
Quick Ratio
3.85%
Cash Position Ratio
2.92%
Performance ratios (change over 4 years) 30-Jun-2020 - 30-Jun-2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-66.59%
Return on assets
-81.33%
Return on sales
23.73%
Return on invested capital
93.56%
Total debt ratio
-455.39%
Debt ratio change over time
-4.55%
Current Ratio
-69.58%
Quick Ratio
-66.72%
Cash Position Ratio
-56.01%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | CDNA | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -6.01% | 15.05% | 35.64% | 7.13% |
| Return on assets | -2.95% | 2.88% | 3.13% | 5.53% |
| Return on sales | -20.43% | 29.62% | 32.25% | 40.49% |
| Return on invested capital | -28.51% | 2.57% | 5.37% | 18.48% |
| Profitability | 0% | 45% | 66% | 80% |
| Total debt ratio | 23.63% | 90.48% | 91% | 25.78% |
| Debt ratio change over time | -4.55% | 326.95% | -8.44% | 1.18% |
| Dept financing | 6% | 50% | 25% | 7% |
| Current Ratio | 4.29% | 0.92% | 1.98% | 5.39% |
| Quick Ratio | 4.04% | 0.81% | 1.56% | 4.63% |
| Cash Position Ratio | 3.18% | 0.39% | 1.05% | 2.91% |
| Liquididy | 75% | 10% | 22% | 53% |
| Short-term ratios | CDNA | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -14.54% | 13.14% | 10.88% | 4.07% |
| Return on assets | -4.05% | 2.1% | 1.54% | 3.03% |
| Return on sales | -27.99% | 21.74% | 18.43% | 30.26% |
| Return on invested capital | -52.17% | 1.95% | 2.74% | 9.55% |
| Profitability | 0% | 65% | 56% | 83% |
| Total debt ratio | 38.01% | 92.68% | 93.24% | 21.84% |
| Debt ratio change over time | -7.26% | 51.04% | -101.54% | 1.43% |
| Dept financing | 10% | 50% | 25% | 7% |
| Current Ratio | 4.29% | 0.92% | 1.98% | 5.39% |
| Quick Ratio | 4.04% | 0.81% | 1.56% | 4.63% |
| Cash Position Ratio | 3.18% | 0.39% | 1.05% | 2.91% |
| Liquididy | 67% | 12% | 26% | 73% |